Breakpoints

123 Episodo

1. #63 – I Never Metapneumovirus that Required Antibiotics: Prevention & Treatment of Common Respiratory Viruses in Adults

   Publicado: 16/9/2022
2. #62 – Novel TheraPOOtics: The Microbiome, C. difficile, and LBPs

   Publicado: 26/8/2022
3. #61 – Dosing Consult: Linezolid Therapeutic Drug Monitoring

   Publicado: 19/8/2022
4. #60 – Going MAD for Non-COVID ID Literature: A Year in Review LIVE from MAD-ID

   Publicado: 22/7/2022
5. #59 – Resistance in Pseudomonas aeruginosa: Pearls and Perils

   Publicado: 15/7/2022
6. #58 – We're Gonorrhea-valuate: Updates and Implementation of STI Treatment Guidelines

   Publicado: 24/6/2022
7. #57 – Dosing Consult: Ceftriaxone

   Publicado: 27/5/2022
8. #56 – Empiric Escalation: Gazing into the Crystal Ball for Multidrug-Resistant Gram-Negatives

   Publicado: 15/4/2022
9. #55 – One World: Global Perspectives in Antimicrobial Stewardship

   Publicado: 25/3/2022
10. #54 – Connecting with our Colleagues: COVID-19 Treatments in Community Pharmacies

    Publicado: 18/3/2022
11. #53 – Abscessus and fortuitum and avium, Oh My!: Updates and Controversies in NTM Management

    Publicado: 18/2/2022
12. #52 – A Conversation with the Authors of IDSA Guidance on Treatment of AmpC, CRAB, and Stenotrophomonas

    Publicado: 28/1/2022
13. #51 – A Conversation with the Authors of IDSA Guidance on Treatment of ESBL, CRE, and DTR Pseudomonas

    Publicado: 21/1/2022
14. #50 – Moving to the Algo-rhythm of IDWeek 2021: Highlights in SoMe and ASP

    Publicado: 17/12/2021
15. #49 – A PGY-What Now? A Primer on ID Pharmacy Fellowships

    Publicado: 3/12/2021
16. #48 – Aligning Goals: Antibiotics in End of Life Care

    Publicado: 19/11/2021
17. #47 – A Nefarious Orchestra: Gram-Negative Resistance Mechanisms Part 2

    Publicado: 29/10/2021
18. #46 – A Nefarious Orchestra: Gram-Negative Resistance Mechanisms Part 1

    Publicado: 22/10/2021
19. #45 – Expectation vs. Reality: An Insider look at the OVERCOME and MERINO-2 trials

    Publicado: 24/9/2021
20. #44 – The VaxScene, a review of the COVID-19 vaccine landscape in the US with a focus on equitable distribution and vaccine hesitancy

    Publicado: 17/9/2021